The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Opioid dependence and addiction during opioid treatment of chronic pain
Abstract
Throughout the long history of opioid drug use by humans, it has been known that opioids are powerful analgesics, but they can cause addiction. It has also been observed, and is now substantiated by multiple reports and studies, that during opioid treatment of severe and short-term pain, addiction arises only rarely. However, when opioids are extended to patients with chronic pain, and therapeutic opioid use is not confined to patients with severe and short-lived pain, compulsive opioid seeking and addiction arising directly from opioid treatment of pain become more visible. Although the epidemiological evidence base currently available is rudimentary, it appears that problematic opioid use arises in some fraction of opioid-treated chronic pain patients, and that problematic behaviors and addiction are problems that need to be addressed. Since the potentially devastating effects of addiction can substantially offset the benefits of opioid pain relief, it seems timely to reexamine addiction mechanisms and their relevance to the practice of long-term opioid treatment for pain. This article reviews the neurobiological and genetic basis of addiction, its terminology and diagnosis, the evidence on addiction rates during opioid treatment of chronic pain and the implications of biological mechanisms in formulating rational opioid treatment regimes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Synaptic Plasticity and Memory: An Evaluation of the Hypothesis
Martin, S. J., Grimwood, P. D., & Morris, R. G. M. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.649 · Cited by 2,794 · cited 2×
“It has been proposed that this type of neuroadaptation occurs through reorganization of neural circuitry produced by increases in synaptic strength (synaptic plasticity), changes in intrinsic excitability (properties or numbers of voltage-dependent ion channels) or actual morphological changes (Nestler, 1996, 2001; Ma…”
BackgroundNEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Inheritance of Alcohol Abuse: Cross-Fostering Analysis of Adopted Men
Cloninger, C. R. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780330019001 · Cited by 1,873
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053570 · Cited by 1,859
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637 · cited 2×
“Opioids induce dopamine release indirectly by decreasing GABA-inhibition via l-opioid receptors in the ventral tegmental area (Johnson and North, 1992; Bonci and Williams, 1997; Cami and Farre, 2003), as well as directly by interacting with opioid receptors in the nucleus accumbens (Nestler, 1996; Hyman and Malenka, 2…”
BackgroundRobinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485 · cited 1×
“(Blazer et al., 1994).”
Incentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435 · cited 1×
“…combined with drug use, form a powerful memory imprint, as in all conditioning responses, that is not easy to eradicate, even after drug cessation (Robinson and Berridge, 1993; Morris et al., 1997; O’Brien et al., 1998; Self and Nestler, 1998; Sell et al., 1999; Shaham et al., 2000; Wise, 2000;…”
BackgroundCARLEZONJR, W., DUMAN, R., & NESTLER, E. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,346
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,313
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
Opioid-induced Hyperalgesia: A Qualitative Systematic Review
Angst, M. S., & Clark, J. D. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00025 · Cited by 1,188
Molecular mechanisms of drug addiction
Nestler, E. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.031 · Cited by 1,108
Addiction Rare in Patients Treated with Narcotics
(1980) · New England Journal of Medicine · doi:10.1056/nejm198001103020221 · Cited by 1,106 · cited 1×
“A classic report (a letter) by Porter and Jick (1980) was taken out of context and often used to support low addiction rates; the report was of 0.03% addiction rates in hospitalized patients (Porter and Jick, 1980).”
BackgroundInfluentialWebster, L. R., & Webster, R. M. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.00072.x · Cited by 1,096 · cited 2×
“(5) They may reflect a need for opioids to relieve a comorbid condition such as depression or anxiety (Webster and Webster, 2005).”
BackgroundChronic pain-associated depression: Antecedent or consequence of chronic pain? A review
Fishbain, D. A., Cutler, R., Rosomoff, H. L., & Rosomoff, R. S. (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199706000-00006 · Cited by 1,074 · cited 1×
“It is less clear, however, which comes first, the pain or the psychopathology (Fishbain et al., 1997).”
BackgroundBond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,074
Kreek, M. J., Nielsen, D. A., Butelman, E. R., & LaForge, K. S. (2005) · Nature Neuroscience · doi:10.1038/nn1583 · Cited by 1,024
Substance Abuse: A Comprehensive Textbook
Lowinson, J. H. (1992) · Cited by 960
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959
Self-citationμ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
Portenoy, R. K., & Foley, K. M. (1986) · Pain · doi:10.1016/0304-3959(86)90091-6 · Cited by 897
Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactions
Mao, J., Price, D. D., & Mayer, D. J. (1995) · Pain · doi:10.1016/0304-3959(95)00073-2 · Cited by 818
Loeser, J. D. (2001) · Cited by 792
Martell, B. A., O'Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., & Fiellin, D. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00006 · Cited by 774
Explaining high rates of depression in chronic pain: A diathesis-stress framework.
Banks, S. M., & Kerns, R. D. (1996) · Psychological Bulletin · doi:10.1037//0033-2909.119.1.95 · Cited by 742
Genome-wide search for genes affecting the risk for alcohol dependence
Reich, T., Edenberg, H. J., Goate, A., Williams, J. T., Rice, J. P., Van Eerdewegh, P., Foroud, T., Hesselbrock, V., Schuckit, M. A., Bucholz, K., et al. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980508)81:3<207::aid-ajmg1>3.0.co;2-t · Cited by 735
Tsuang, M. T., Lyons, M. J., Meyer, J. M., Doyle, T., Eisen, S. A., Goldberg, J., True, W., Lin, N., Toomey, R., & Eaves, L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.967 · Cited by 710 · cited 2×
“5, depending on the drug and the study (Cloninger et al., 1981; Cadoret et al., 1986; Pickens et al., 1991; Bierut et al., 1998; Tsuang et al., 1998; Kendler et al., 2003).”
BackgroundInfluentialStress-induced relapse to heroin and cocaine seeking in rats: a review
Shaham, Y., Erb, S., & Stewart, J. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00024-2 · Cited by 700
Kendler, K. S., Jacobson, K. C., Prescott, C. A., & Neale, M. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.687 · Cited by 693
Conditioning factors in drug abuse: can they explain compulsion?
O'Brien, C. P., Childress, A. R., Ehrman, R., & Robbins, S. J. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200103 · Cited by 680
Chronic Pain and Psychopathology: Research Findings and Theoretical Considerations
Dersh, J., Polatin, P. B., & Gatchel, R. J. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200209000-00010 · Cited by 676
Edenberg, H. J., Dick, D. M., Xuei, X., Tian, H., Almasy, L., Bauer, L. O., Crowe, R. R., Goate, A., Hesselbrock, V., Jones, K., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/383283 · Cited by 655
Opioid pseudoaddiction — an iatrogenic syndrome
Weissman, D. E., & Haddox, D. J. (1989) · Pain · doi:10.1016/0304-3959(89)90097-3 · Cited by 647
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620 · cited 4×
“Deletion of this gene also results in decrease or elimination of reward for cocaine and alcohol (Kieffer and Gavériaux-Ruff, 2002).”
BackgroundInfluentialFudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577 · cited 1×
“Buprenorphine, a partial l-agonist, is an alternative for maintenance treatment of addiction, and has recently been approved in the United States for clinic and office-based treatment of addiction (in large part to avoid the regulatory onus and stigma of methadone) (Fiellin and O’Connor, 2002; Fudala et al., 2003; Kra…”
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · cited 1×
“Several studies have consistently shown that the A118G variant affects opioid-mediated control of the hypothalamic-pituitary-adrenal (HPA) stress-responsive axis and that this may have implications for the treatment of alcoholism with opioid antagonists (Wand et al., 2002; Oslin et al., 2003).”
BackgroundHope, B. T., Nye, H. E., Kelz, M. B., Self, D. W., Iadarola, M. J., Nakabeppu, Y., Duman, R. S., & Nestler, E. J. (1994) · Neuron · doi:10.1016/0896-6273(94)90061-2 · Cited by 563
McWilliams, L. A., Goodwin, R. D., & Cox, B. J. (2004) · Pain · doi:10.1016/j.pain.2004.06.002 · Cited by 562
Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria
Fishbain, D. A., Goldberg, M., Meagher, R. B., Steele, R., & Rosomoff, H. (1986) · Pain · doi:10.1016/0304-3959(86)90074-6 · Cited by 561
Benzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 534
Opioid therapy for chronic nonmalignant pain: a review of the critical issues
Portenoy, R. K. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00187-5 · Cited by 533
Gatchel, R. J., Polatin, P. B., & Mayer, T. G. (1995) · Spine · doi:10.1097/00007632-199512150-00011 · Cited by 531
Psychiatric Illness and Chronic Low-Back Pain: The Mind and the Spine—Which Goes First?
Polatin, P. B., Kinnedy, R. K., Gatchel, R. J., Lillo, E., & Mayer, T. G. (1993) · Spine · doi:10.1097/00007632-199301000-00011 · Cited by 511
Trends in Medical Use and Abuse of Opioid Analgesics
Joranson, D. E. (2000) · JAMA · doi:10.1001/jama.283.13.1710 · Cited by 504
Chronic pain, chronic stress and depression: Coincidence or consequence?
Blackburn‐Munro, G., & Blackburn‐Munro, R. E. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.0007-1331.2001.00727.x · Cited by 493
Bierut, L. J., Dinwiddie, S. H., Begleiter, H., Crowe, R. R., Hesselbrock, V., Nurnberger, J. I., Porjesz, B., Schuckit, M. A., & Reich, T. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.982 · Cited by 489
Edlund, M. J., Steffick, D., Hudson, T., Harris, K. M., & Sullivan, M. (2007) · Pain · doi:10.1016/j.pain.2007.02.014 · Cited by 483
Heterogeneity in the Inheritance of Alcoholism: A Study of Male and Female Twins
Pickens, R. W. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250021002 · Cited by 482
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Acute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy
Alford, D. P., Compton, P., & Samet, J. H. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-2-200601170-00010 · Cited by 468
Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy
Mao, J. (2002) · Pain · doi:10.1016/s0304-3959(02)00422-0 · Cited by 462
Mao, J., Price, D., & Mayer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02301.1994 · Cited by 458
Chu, L. F., Clark, D. J., & Angst, M. S. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.08.001 · Cited by 426
Historical review: molecular and cellular mechanisms of opiate and cocaine addiction
Nestler, E. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.005 · Cited by 425
Addiction to opioids in chronic pain patients: A literature review
Højsted, J., & Sjøgren, P. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2006.08.004 · Cited by 424 · cited 2×
“, 2004), some of the discrepancies in findings clearly depending on the criteria used by the investigators to define addiction (Chabal et al., 1997; Fishbain et al., 1999; Joranson et al., 2000; Weaver and Schnoll, 2002a; Cowan et al., 2003; Manchikanti et al., 2003; Savage et al., 2003; Passik and Kirsh, 2004; Woolf…”
BackgroundMcQuay, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03528-x · Cited by 414
Diagnosis and Symptoms of Depression in Opiate Addicts: Course and Relationship to Treatment Outcome
Rounsaville, B. J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020021004 · Cited by 410
Mao, J., Sung, B., Ji, R.-R., & Lim, G. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08312.2002 · Cited by 409
Klepstad, P., Rakvåg, T. T., Kaasa, S., Holthe, M., Dale, O., Borchgrevink, P. C., Baar, C., Vikan, T., Krokan, H. E., & Skorpen, F. (2004) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2004.00517.x · Cited by 381
Kreek, M. J., LaForge, K. S., & Butelman, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 374
Sinha, R., Talih, M., Malison, R., Cooney, N., Anderson, G. M., & Kreek, M. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1525-8 · Cited by 366
Neural substrates of opiate withdrawal
Koob, G. F., Maldonado, R., & Stinus, L. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90171-4 · Cited by 359
Drug Abuse, Dependence, and Addiction in Chronic Pain Patients
Fishbain, D. A., Rosomoff, H. L., & Rosomoff, R. S. (1992) · The Clinical Journal of Pain · doi:10.1097/00002508-199206000-00003 · Cited by 357
A Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation
Berke, J. D., Paletzki, R. F., Aronson, G. J., Hyman, S. E., & Gerfen, C. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05301.1998 · Cited by 356
Validation of a screener and opioid assessment measure for patients with chronic pain
Butler, S. F., Budman, S. H., Fernandez, K., & Jamison, R. N. (2004) · Pain · doi:10.1016/j.pain.2004.07.026 · Cited by 355
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 351
An Adoption Study of Genetic and Environmental Factors in Drug Abuse
Cadoret, R. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800120017004 · Cited by 348
Rapp, S. E., Ready, B. L., & Nessly, M. L. (1995) · Pain · doi:10.1016/0304-3959(94)00168-e · Cited by 346
Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance
Vanderah, T. W., Gardell, L. R., Burgess, S. E., Ibrahim, M., Dogrul, A., Zhong, C.-M., Zhang, E.-T., Malan, T. P., Ossipov, M. H., Lai, J., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-07074.2000 · Cited by 344
Magni, G., Caldieron, C., Rigatti-Luchini, S., & Merskey, H. (1990) · Pain · doi:10.1016/0304-3959(90)90027-b · Cited by 343
Prescription Opiate Abuse in Chronic Pain Patients: Clinical Criteria, Incidence, and Predictors
Chabal, C., Erjavec, M. K., Jacobson, L., Mariano, A., & Chaney, E. (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199706000-00009 · Cited by 304
Perioperative Management of Acute Pain in the Opioid-dependent Patient
Mitra, S., Sinatra, R. S., & Warltier, D. C. (2004) · Anesthesiology · doi:10.1097/00000542-200407000-00032 · Cited by 301
Relapse to drug-seeking: neural and molecular mechanisms
Self, D. W., & Nestler, E. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00065-9 · Cited by 295
DOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Buprenorphine: Considerations for Pain Management
Johnson, R. E., Fudala, P. J., & Payne, R. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.07.005 · Cited by 290 · cited 1×
“Both of these drugs provide protection from withdrawal for approximately 24–48 h, while their analgesic effects last only 4–8 h, so that a major difference between pain and addiction treatment using these agents is that dosing is more frequent for pain (Fishman et al., 2002; Walsh and Eissenberg, 2003; Johnson et al.,…”
BackgroundIncreased probability of GABA release during withdrawal from morphine
Bonci, A., & Williams, J. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00796.1997 · Cited by 286 · cited 2×
“…induce dopamine release indirectly by decreasing GABA-inhibition via l-opioid receptors in the ventral tegmental area (Johnson and North, 1992; Bonci and Williams, 1997; Cami and Farre, 2003), as well as directly by interacting with opioid receptors in the nucleus accumbens (Nestler, 1996;…”
BackgroundOpioids: cellular mechanisms of tolerance and physical dependence
Bailey, C. P., & Connor, M. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.012 · Cited by 285
Lu, L., Shepard, J. D., Scott Hall, F., & Shaham, Y. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00073-3 · Cited by 276
Vanderah, T. W., Ossipov, M. H., Lai, J., Malan, P. T., & Porreca, F. (2001) · Pain · doi:10.1016/s0304-3959(01)00311-6 · Cited by 271
PATTERNS OF NARCOTIC DRUG USE IN A CANCER PAIN CLINIC*
Kanner, R. M., & Foley, K. M. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb12804.x · Cited by 271
Screening for Addiction in Patients with Chronic Pain and “Problematic” Substance Use
Compton, P., Darakjian, J., & Miotto, K. (1998) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(98)00110-9 · Cited by 266
An essential role for ΔFosB in the nucleus accumbens in morphine action
Zachariou, V., Bolanos, C. A., Selley, D. E., Theobald, D., Cassidy, M. P., Kelz, M. B., Shaw-Lutchman, T., Berton, O., Sim-Selley, L. J., Dileone, R. J., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1636 · Cited by 266
Porreca, F., Burgess, S. E., Gardell, L. R., Vanderah, T. W., Malan, T. P., Ossipov, M. H., Lappi, D. A., & Lai, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05281.2001 · Cited by 266
Under Siege: The Brain on Opiates
Nestler, E. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80110-5 · Cited by 260
Chronic pain: lifetime psychiatric diagnoses and family history
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1156 · Cited by 257
L??tsch, J., Skarke, C., Liefhold, J., & Geisslinger, G. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443140-00003 · Cited by 256
Uhl, G. R., Liu, Q.-R., Walther, D., Hess, J., & Naiman, D. (2001) · The American Journal of Human Genetics · doi:10.1086/324467 · Cited by 251
Opioid switching: A systematic and critical review
Mercadante, S., & Bruera, E. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.03.001 · Cited by 249
Recommendations for using opioids in chronic non‐cancer pain
Kalso, E., Allan, L., Dellemijn, P. L. I., Faura, C. C., Ilias, W. K., Jensen, T. S., Perrot, S., Plaghki, L. H., & Zenz, M. (2003) · European Journal of Pain · doi:10.1016/s1090-3801(02)00143-x · Cited by 249
Wand, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00294-9 · Cited by 246
Schaible, H.-G., & Richter, F. (2004) · Langenbeck's Archives of Surgery · doi:10.1007/s00423-004-0468-9 · Cited by 245
Skarke, C., Darimont, J., Schmidt, H., Geisslinger, G., & Lötsch, J. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.5 · Cited by 226
Definitions related to the medical use of opioids: Evolution towards universal agreement
Savage, S. R., Joranson, D. E., Covington, E. C., Schnoll, S. H., Heit, H. A., & Gilson, A. M. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00219-7 · Cited by 221 · cited 4×
“, 2004), some of the discrepancies in findings clearly depending on the criteria used by the investigators to define addiction (Chabal et al., 1997; Fishbain et al., 1999; Joranson et al., 2000; Weaver and Schnoll, 2002a; Cowan et al., 2003; Manchikanti et al., 2003; Savage et al., 2003; Passik and Kirsh, 2004; Woolf…”
BackgroundInfluentialPostoperative Hyperalgesia: Its Clinical Importance and Relevance
Wilder-Smith, O. H. G., & Arendt-Nielsen, L. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00028 · Cited by 220
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic
WALSH, S. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00056-5 · Cited by 219
Adams, L. L., Gatchel, R. J., Robinson, R. C., Polatin, P., Gajraj, N., Deschner, M., & Noe, C. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.10.009 · Cited by 216
Opioid tolerance: the clinical perspective
Collett, B. J. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.58 · Cited by 207
Regulations of opioid dependence by opioid receptor types
Narita, M., Funada, M., & Suzuki, T. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00099-1 · Cited by 190
A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy
PASSIK, S. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90057-4 · Cited by 189
MAJOR PSYCHOLOGICAL DISORDERS IN ACUTE AND CHRONIC TMD: AN INITIAL EXAMINATION
GATCHEL, R. J., GAROFALO, J. P., ELLIS, E., & HOLT, C. (1996) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1996.0450 · Cited by 187
The DIRE Score: Predicting Outcomes of Opioid Prescribing for Chronic Pain
Belgrade, M. J., Schamber, C. D., & Lindgren, B. R. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2006.03.001 · Cited by 185
Wasan, A. D., Davar, G., & Jamison, R. (2005) · Pain · doi:10.1016/j.pain.2005.08.006 · Cited by 180
Neural responses to salient visual stimuli
Morris, J. S., Friston, K. J., & Dolan, R. J. (1997) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1997.0109 · Cited by 175
Wang, H.-Y., Friedman, E., Olmstead, M. C., & Burns, L. H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.003 · Cited by 174
Chefer, V. I., Czyzyk, T. A., Bolan, E. A., Morón, J. A., Pintar, J. E., & Shippenberg, T. S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0854-05.2005 · Cited by 173
Opioid receptor and peptide gene polymorphisms: potential implications for addictions
LaForge, K. S., Yuferov, V. P., & Kreek, M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00819-0 · Cited by 167
Romberg, R. R., Olofsen, E., Bijl, H., Taschner, P. E. M., Teppema, L. J., Sarton, E. Y., van Kleef, J. W., & Dahan, A. (2005) · Anesthesiology · doi:10.1097/00000542-200503000-00008 · Cited by 166
Jovey, R. D., Ennis, J., Gardner‐Nix, J., Goldman, B., Hays, H., Lynch, M., & Moulin, D. E. (2003) · Pain Research and Management · doi:10.1155/2003/436716 · Cited by 163
Dunbar, S. A., & Katz, N. P. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00165-4 · Cited by 163
Straub, R. E., Sullivan, P. F., Ma, Y., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Kadambi, B., Sadek, H., Silverman, M. A., Webb, B. T., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000518 · Cited by 161
Activation of reward circuitry in human opiate addicts
Sell, L., Morris, J., Bearn, J., Frackowiak, R. S. J., Friston, K. J., & Dolan, R. J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00522.x · Cited by 160
Genes Associated With Addiction: Alcoholism, Opiate, and Cocaine Addiction
Kreek, M. J., Nielsen, D. A., & LaForge, K. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:085 · Cited by 159
Addiction Becomes a Brain Disease
Wise, R. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81134-4 · Cited by 158
Office-Based Treatment of Opioid-Dependent Patients
Fiellin, D. A., & O'Connor, P. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013579 · Cited by 148
DYER, K., Foster, D. J. R., White, J. M., Somogyi, A. A., Menelaou, A., & Bochner, F. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90090-5 · Cited by 148
TAYLOR, D. A. H. B., & Fleming, W. W. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29505-7 · Cited by 147
Are μ-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch, J., & Geißlinger, G. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.006 · Cited by 146
Analgesic overuse among subjects with headache, neck, and low-back pain
Zwart, J. ‐., Dyb, G. A., Hagen, K., Svebak, S., Stovner, L. J., & Holmen, J. (2004) · Neurology · doi:10.1212/01.wnl.0000123262.96132.fc · Cited by 145
Nitsche, J. F., Schuller, A. G., King, M. A., Zengh, M., Pasternak, G. W., & Pintar, J. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10906.2002 · Cited by 144
Are NMDA receptors involved in opiate-induced neural and behavioral plasticity?
Trujillo, K. A. (2000) · Psychopharmacology · doi:10.1007/s002130000416 · Cited by 144
Ozaki, S., Narita, M., Narita, M., Iino, M., Sugita, J., Matsumura, Y., & Suzuki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01071.x · Cited by 142 · cited 1×
“Indeed, animal and human studies support the contention that opioid euphoria and reward are attenuated by pain (Zacny et al., 1996; Ozaki et al., 2002; Ozaki et al., 2003; Narita et al., 2005; Alford et al., 2006).”
BackgroundOpioid and anti‐opioid peptides
Cesselin, F. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00517.x · Cited by 142
Treating Opioid Dependence: Growing Implications for Primary Care
Krantz, M. J., & Mehler, P. S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.277 · Cited by 138
Methadone Reincarnated: Novel Clinical Applications with Related Concerns
Fishman, S. M., Wilsey, B. L., Mahajan, G., & Molina, P. E. (2002) · Pain Medicine · doi:10.1046/j.1526-4637.2002.02047.x · Cited by 138
Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
Watts, V. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.1 · Cited by 135
Genomewide Linkage Scan for Opioid Dependence and Related Traits
Gelernter, J. E., Panhuysen, C. I. M., Wilcox, M., HESSELBROCK, V. M., Rounsaville, B. J., Poling, J. C., Weiss, R. D., Sonne, S. C., Zhao, H., Farrer, L. A., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503631 · Cited by 134
Gelernter, J. E., Panhuysen, C. I. M., Weiss, R. D., Brady, K. T., HESSELBROCK, V. M., Rounsaville, B. J., Poling, J. C., Wilcox, M., Farrer, L. A., & Kranzler, H. R. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30189 · Cited by 134
Validity of Self-Reported Drug Use in Chronic Pain Patients
Fishbain, D. A., Cutler, R. B., Rosomoff, H. L., & Rosomoff, R. S. (1999) · Clinical Journal of Pain · doi:10.1097/00002508-199909000-00005 · Cited by 133
Opioid-induced hyperalgesia: A qualitative systematic review
Angst, M. S., & Clark, J. D. (2006) · Acute Pain · doi:10.1016/j.acpain.2006.09.018 · Cited by 130
Narita, M., Kishimoto, Y., Ise, Y., Yajima, Y., Misawa, K., & Suzuki, T. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300527 · Cited by 128 · cited 1×
“Indeed, animal and human studies support the contention that opioid euphoria and reward are attenuated by pain (Zacny et al., 1996; Ozaki et al., 2002; Ozaki et al., 2003; Narita et al., 2005; Alford et al., 2006).”
BackgroundGenetic and Environmental Influences on Transitions in Drug Use
Tsuang, M. T., Lyons, M. J., Harley, R. M., Xian, H., Eisen, S. A., Goldberg, J. H., True, W. R., & Faraone, S. V. (1999) · Behavior Genetics · doi:10.1023/a:1021635223370 · Cited by 121
LEVIN, F. R., & Kleber, H. D. (1995) · Harvard Review of Psychiatry · doi:10.3109/10673229509017144 · Cited by 121
Childress, A. R. (1986) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(86)90018-8 · Cited by 119
A Survey of Chronic Noncancer Pain Patients Prescribed Opioid Analgesics
Cowan, D. T., Wilson‐Barnett, J., Griffiths, P., & Allan, L. G. (2003) · Pain Medicine · doi:10.1111/j.1526-4637.2003.03038.x · Cited by 118
Chindalore, V. L., Craven, R. A., Yu, K., Butera, P. G., Burns, L. H., & Friedmann, N. (2005) · Journal of Pain · doi:10.1016/j.jpain.2005.01.356 · Cited by 115
Pharmacokinetic considerations in abuse liability evaluation
Farré, M., & Camí, J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01754.x · Cited by 113
Potent opioids for chronic musculoskeletal pain: flying blind?
Korff, M. V., & Deyo, R. A. (2004) · Pain · doi:10.1016/j.pain.2004.02.019 · Cited by 107
Prevalence of psychopathology in acute and chronic low back pain patients
Kinney, R. K., Gatchel, R. J., Polatin, P. B., Fogarty, W. T., & Mayer, T. G. (1993) · Journal of Occupational Rehabilitation · doi:10.1007/bf01078162 · Cited by 106
Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program
Saper, J. R., Lake, A. E., Hamel, R. L., Lutz, T. E., Branca, B., Sims, D., & Kroll, M. (2004) · Neurology · doi:10.1212/01.wnl.0000125189.17830.02 · Cited by 105
The Diversion of Prescription Drugs by Health Care Workers in Cincinnati, Ohio
Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Burke, J. J. (2006) · Substance Use & Misuse · doi:10.1080/10826080500391829 · Cited by 102
Abuse Liability in Opioid Therapy for Pain Treatment in Patients With an Addiction History
Weaver, M. F., & Schnoll, S. H. (2002) · Clinical Journal of Pain · doi:10.1097/00002508-200207001-00007 · Cited by 102
Chronic opioid therapy for non-cancer pain
Collett, B.-J. (2001) · British Journal of Anaesthesia · doi:10.1093/bja/87.1.133 · Cited by 98
Schluger, J. H., Ho, A., Borg, L., Porter, M., Maniar, S., Gunduz, M., Perret, G., King, A. C., & Kreek, M. J. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03931.x · Cited by 97
Shippenberg, T. S., LeFevour, A., & Thompson, A. C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01614-2 · Cited by 93
Schluger, J. H., Borg, L., Ho, A., & Kreek, M. J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00222-0 · Cited by 92
Pain management and symptoms of substance dependence among patients with sickle cell disease
Elander, J., Lusher, J. M., Bevan, D. H., & Telfer, P. T. (2003) · Social Science & Medicine · doi:10.1016/s0277-9536(02)00553-1 · Cited by 91
Drug Addictions: Molecular and Cellular Endpoints
Kreek, M. J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03557.x · Cited by 91
A locus and mechanism of action for associative morphine tolerance
Mitchell, J., Basbaum, A. I., & Fields, H. L. (2000) · Nature Neuroscience · doi:10.1038/71120 · Cited by 87
Mercadante, S., Villari, P., Ferrera, P., Porzio, G., Aielli, F., Verna, L., & Casuccio, A. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.01.013 · Cited by 86
de León-Casasola, O. A., Myers, D. P., Donaparthi, S., Bacon, D. R., Peppriell, J., Rempel, J., & Lema, M. J. (1993) · PubMed · Cited by 85
Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers
Lötsch, J., & Geißlinger, G. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500362 · Cited by 85
An Opiate Cocktail that Reduces Morphine Tolerance and Dependence
Li, H., & Whistler, J. L. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.052 · Cited by 84
Uhl, G. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.001 · Cited by 84
Wiesenfeld‐Hallin, Z., & Xu, X. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01305-x · Cited by 83
Ozaki, S., Narita, M., Narita, M., Iino, M., Miyoshi, K., & Suzuki, T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00699-1 · Cited by 79
Opioid Therapy in Patients with a History of Substance Abuse
Passik, S. D., & Kirsh, K. L. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00002 · Cited by 77
Addiction, Physical Dependence, and Tolerance
Heit, H. A. (2003) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v17n01_03 · Cited by 75
Opioid tolerance and dependence — do they matter?
Jage, J. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2004.11.009 · Cited by 72
Woolf, C. J., & Hashmi, M. (2004) · PubMed · Cited by 69
Wanted: a public health approach to prescription opioid abuse and diversion
Joranson, D. E., & Gilson, A. M. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1293 · Cited by 68
Clinicians' attitudes about prolonged use of opioids and the issue of patient heterogeneity
Turk, D. C. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00188-3 · Cited by 68
Olmstead, M. C., & Burns, L. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0022-7 · Cited by 65
Alprazolam absorption kinetics affects abuse liability
Mumford, G. K., Evans, S. M., Fleishaker, J. C., & Griffiths, R. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90162-0 · Cited by 63
Substance abuse among patients with chronic back pain.
Brown, R. L., Patterson, J. J., Rounds, L. A., & Papasouliotis, O. (1996) · PubMed · Cited by 61
Wang, X., Zhou, Y., Spangler, R., Ho, A., Han, J.-S., & Kreek, M. J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00021-2 · Cited by 59
Passik, S. D., & Kirsh, K. L. (2003) · Pain Medicine · doi:10.1046/j.1526-4637.2003.03018.x · Cited by 58
Inhibition of Cytochrome P450 2D6 Modifies Codeine Abuse Liability
Kathiramalainathan, K., Kaplan, H. L., Romach, M. K., Busto, U. E., Li, N.-Y., Säwe, J., Tyndale, R. F., & Sellers, E. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00008 · Cited by 54
Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance
Xu, X., Colpaert, F. C., & Wiesenfeld‐Hallin, Z. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.005 · Cited by 52
Manchikanti, L., Pampati, V., Damron, K. S., Beyer, C. D., Barnhill, R. C., & Fellows, B. (2003) · PubMed · Cited by 48
Zacny, J. P., McKay, M. A., Toledano, A. Y., Marks, S., Young, C. J., Klock, P. A., & Apfelbaum, J. L. (1996) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(96)01274-4 · Cited by 47
Ultra-Low Dose Oral Naltrexone Decreases Side Effects and Potentiates the Effect of Methadone
Cruciani, R. A., Lussier, D., Miller-Saultz, D., & Arbuck, D. M. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00139-8 · Cited by 44
Narcotic addiction in patients with chronic pain
Evans, P. J. (1981) · Anaesthesia · doi:10.1111/j.1365-2044.1981.tb10323.x · Cited by 44
The development of morphine tolerance and dependence in rats with chronic pain
Yu, W., Hao, J., Xu, X., & Wiesenfeld‐Hallin, Z. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00132-7 · Cited by 41
Pain Clinicians' Rankings of Aberrant Drug-Taking Behaviors
Passik, S. D., Kirsh, K. L., Whitcomb, L., Dickerson, P. K., & Theobald, D. (2002) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v16n04_04 · Cited by 40
Chronic pain and substance abuse: A pilot study of opioid maintenance
Kennedy, J. A. (1990) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(90)90046-s · Cited by 37
A cell biologist’s perspective on physiological adaptation to opiate drugs
von Zastrow, M. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.05.007 · Cited by 37
Guidelines for the Use of Controlled Substances in the Management of Chronic Pain
Atluri, S., Boswell, M. V., Hansen, H. C., Trescot, A. M., Singh, V., & Jordan, A. E. (2003) · Pain Physician · doi:10.36076/ppj.2003/6/233 · Cited by 36
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males
Roset, P. N., Farré, M., de la Torre, R., Más, M., Menoyo, E., Hernández, C., & Camı́, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00127-2 · Cited by 35
Treatment of Codeine Dependence With Inhibitors of Cytochrome P450 2D6
Fernandes, L. C., Kilicarslan, T., Kaplan, H. L., Tyndale, R. F., Sellers, E. M., & Romach, M. K. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00014 · Cited by 29
Should Opioid Analgesics Be Used in the Management of Chronic Pain in Opiate Addicts?
Collins, E. D., & Streltzer, J. (2003) · American Journal on Addictions · doi:10.1080/10550490390201362 · Cited by 28
What have we learned from three decades of methadone maintenance treatment?
Dole, V. P. (1994) · Drug and Alcohol Review · doi:10.1080/09595239400185661 · Cited by 27
Compensation and non-compensation chronic pain patients compared for DSM-III operational diagnoses
Fishbain, D. A., GOLDBERG, M. L., Labbé, E. E., Steele, R., & Rosomoff, H. L. (1988) · Pain · doi:10.1016/0304-3959(88)90068-1 · Cited by 26
Chronic pain and narcotic addiction: A multitherapeutic approach—A pilot study
Khatami, M., WOODY, G. E., & O’Brien, C. P. (1979) · Comprehensive Psychiatry · doi:10.1016/0010-440x(79)90059-2 · Cited by 18
Fine, P. G. (2004) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v18n03_08 · Cited by 18
Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program
Lockwood, A. H. (2004) · Neurology · doi:10.1212/wnl.63.12.2459 · Cited by 8
Newman, R. G. (2004) · American Journal on Addictions · doi:10.1080/10550490490512861 · Cited by 5
Cited by
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
Opioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
A common neurobiology for pain and pleasure
Leknes, S., & Tracey, I. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2333 · Cited by 784
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
De Facto Long-term Opioid Therapy for Noncancer Pain
Korff, M. V., Saunders, K., Thomas Ray, G., Boudreau, D., Campbell, C., Merrill, J., Sullivan, M. D., Rutter, C. M., Silverberg, M. J., Banta-Green, C., et al. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318169d03b · Cited by 662
Metadata
- Authors
- Ballantyne, J. C., & LaForge, S. K.
- Venue
- Pain
- Published
- 2007-06
- Volume
- 129
- Issue
- 3
- Pages
- 235-255
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1977865300
- Cited by
- 447
- References
- 194
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.